Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0086543 (
cataract
)
29,165
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The bifunctional protein
DCoH
(Dimerizing Cofactor for HNF1) acts as an enzyme in intermediary metabolism and as a binding partner of the HNF1 family of transcriptional activators. HNF1 proteins direct the expression of a variety of genes in the liver, kidney, pancreas, and gut and are critical to the regulation of glucose homeostasis. Mutations of the HNF1alpha gene underlie maturity onset diabetes of the young (MODY3) in humans.
DCoH
acts as a cofactor for HNF1 that stabilizes the dimeric HNF1 complex.
DCoH
also catalyzes the recycling of tetrahydrobiopterin, a cofactor of aromatic amino acid hydroxylases. To examine the roles of
DCoH
, a targeted deletion allele of the murine
DCoH
gene was created. Mice lacking
DCoH
are viable and fertile but display hyperphenylalaninemia and a predisposition to
cataract
formation. Surprisingly, HNF1 function in
DCoH
null mice is only slightly impaired, and mice are mildly glucose-intolerant in contrast to HNF1alpha null mice, which are diabetic.
DCoH
function as it pertains to HNF1 activity appears to be partially complemented by a newly identified homolog, DCoH2.
...
PMID:Hyperphenylalaninemia and impaired glucose tolerance in mice lacking the bifunctional DCoH gene. 1201 Oct 81